All Stories

  1. Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study
  2. Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis
  3. Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome
  4. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort
  5. Developing new evaluation methods in systemic lupus erythematosus
  6. MMF in Lupus
  7. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases
  8. A Multilocus Genetic Study in a Cohort of Italian SLE Patients Confirms the Association with STAT4 Gene and Describes a New Association with HCP5 Gene
  9. Ultrasonographic Evaluation of Renal Resistive Index in Patients with Lupus Nephritis: Correlation with Histologic Findings
  10. Decrease of Asymmetric Dimethyl Arginine After Anti‐TNF Therapy in Patients with Rheumatoid Arthritis
  11. Emergence of Antinuclear Antibodies in Psoriatic Patients Treated with Infliximab: Personal Experience and Literature Review
  12. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome
  13. Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis
  14. TLC Immunostaining for Detection of “Antiphospholipid” Antibodies
  15. The Mosaic of “Seronegative” Antiphospholipid Syndrome
  16. High Prevalence of Antinuclear Antibodies in Children with Thyroid Autoimmunity
  17. The Role of Disease Activity Score 28 in the Evaluation of Articular Involvement in Systemic Lupus Erythematosus
  18. Corrigendum to “Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review” [Leuk. Res. 36 (2012) e199–e201]
  19. Evaluation of the Patient Acceptable Symptom State (PASS) in Italian Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices
  20. TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development
  21. Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study
  22. Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review
  23. Does seronegative antiphospholipid syndrome really exist?
  24. Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage
  25. Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus
  26. Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome
  27. Gender Disparity in Susceptibility to Oxidative Stress and Apoptosis Induced by Autoantibodies Specific to RLIP76 in Vascular Cells
  28. New autoantigens in the antiphospholipid syndrome
  29. The Persistent Challenge of Lupus Nephritis
  30. Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coin
  31. Toll-like Receptors and Lupus Nephritis
  32. Low incidence of flare and persistent active disease in a cohort of Italian patients with systemic lupus erythematosus: Comment on the article by Nikpour et al
  33. Seronegative Autoimmune Diseases
  34. Vaccination and autoimmune rheumatic diseases
  35. Screening of a microvascular endothelial cDNA library identifies rabaptin 5 as a novel autoantigen in Alzheimer's disease
  36. Anti–β2‐glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts
  37. Infliximab Treatment for Ocular and Extraocular Manifestations of Behçet's Disease
  38. Vaccination and Rheumatic Diseases: Is There Still a Dilemma?
  39. Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: A role for scintigraphy with 99mTc‐infliximab
  40. Soluble CD154 plasma levels in patients with systemic lupus erythematosus: Modulation by antiphospholipid antibodies
  41. Role of anti–glial fibrillary acidic protein antibodies in the pathogenesis of neuropsychiatric systemic lupus erythematosus should be clarified: comment on the article by Trysberg et al
  42. Spondyloarthropathy and chronic intestinal inflammation in children: a new entity in the spectrum of pediatric inflammatory bowel disease?
  43. Anti-carbonic Anhydrase II Antibodies in Systemic Sclerosis: Association with Lung Involvement
  44. Increased Eosinophil Protein X Levels in Chronic Fatigue Syndrome
  45. Cyclosporin and Cancer
  46. Antiphospholipid antibodies and thrombosis
  47. Churg-Strauss syndrome during pregnancy after steroid withdrawal
  48. Serum Anti-β2-glycoprotein I Antibodies from Patients with Antiphospholipid Antibody Syndrome Bind Central Nervous System Cells
  49. Saddle Nose